OrthAlign completes $10M financing round — aims to transform TJR

OrthAlign raised $10 million through a series D financing round to fuel product development as the company expands its scope of operation.

Here's what you should know:

1. OrthAlign has an established total knee surgery solution, KneeAlign. The company is in the midst of further developing solutions for total knee, partial knee and total hip replacement surgeries.

2. The company will use new funds to support commercial expansion, while also investing in U.S. and international markets.

3. OrthAlign CEO Eric Timko said in a release, "We are no longer a single-solution provider, and have rapidly expanded our commercial platform technology to include solutions for partial knee replacement with our UniAlign application. Our solution for total hip replacement, HipAlign, supports both posterior- and direct anterior approaches and is currently in a limited user release with full-commercialization slated for 2018."

4. River Cities Capital Funds, California Technology Ventures, Research Corp. Technologies and Mutual Capital Partners led the investment round.

More articles on orthopedics:
NewYork-Presbyterian Lawrence, Columbia University collaborate to expand orthopedic options
Georgia health system's musculoskeletal center passes halfway point — 3 insights
OrthoIllinois building new $9M multispecialty clinic — 4 key notes

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months